TFE3 fusion proteins are the oncogenic drivers of translocation renal cell carcinoma but their mechanism of action remains ...

Combined, these findings show that CMA displays a broad targetability on multiple steps of the EMT process and indicate a substantial role of CMA in regulating the stability of pro-metastatic and ...

Researchers at Karolinska Institutet, led by Dr. Helin Norberg and Dr. Erik Norberg, have identified a previously unknown mechanism that affects the ability of cancer cells to spread in the body.

Teddi Mellencamp is in the fight of her life. After undergoing surgery last month to remove brain tumors, the former “Real Housewives of Beverly Hills” star, 43, revealed more cancer has ...

Teddi Mellencamp’s doctors discovered more tumors in her body after she underwent emergency brain surgery last month. The "Real Housewives of Beverly Hills" star shared a health update on her ...

Ashley Robinson passed "the most insane amount of blood," but doctors said there was "no chance" he had cancer and diagnosed him with hemorrhoids Kennedy News & Media A chef, who was planning his ...

"These are all a direct result of my melanoma,” the podcast host wrote in a Thursday, March 6 Instagram post Charna Flam is a writer-reporter at PEOPLE. She has been working at PEOPLE since 2023.

Teddi Mellencamp is sharing an update about her cancer treatment. The reality star, 43, revealed on Instagram that a recent scan found she has “multiple tumors” in her brain that “weren’t ...

The reality star previously revealed she was diagnosed with a brain tumor. Teddi Mellencamp says she has "multiple tumors" after undergoing scans. The former "Real Housewives of Beverly Hills ...

Molecular Science and Biomedicine Laboratory (MBL), State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Chemistry and Chemical Engineering, College of Biology, Aptamer Engineering ...

About 18 years ago, a 4-year-old girl with a rare nerve cell cancer received an infusion of immune cells that were genetically engineered to fight the disease. Since then, she has remained cancer ...

HER2-Selective Tyrosine Kinase Inhibitor, Zongertinib (BI 1810631), in Patients With Advanced/Metastatic Solid Tumors With HER2 Alterations: A Phase Ia Dose-Escalation Study The article by Mascarenhas ...